Feasibility of paired non-invasive blood flow and tissue oxygen monitoring to detect limb ischemia during lithotomy-position surgeries
Official title: Feasibility and Clinical Utility of Paired Non-Invasive Hemodynamic and Tissue Oximetry Monitoring to Detect Limb Ischemia in Lithotomy-Positioned Surgeries
Run by The University of Texas Health Science Center, Houston · NCT07387653 · Data updated 2026-11-12
This study tests whether using combined non-invasive blood flow monitoring and tissue oxygen sensors during long lithotomy surgeries can help detect early limb ischemia in adults.
Quick facts
| Study type | Observational |
|---|---|
| Sex | Women only |
| Enrollment | 30 (estimated) |
| Sponsor | The University of Texas Health Science Center, Houston Academic / other |
| Locations | 2 sites (Houston, Texas and 1 other locations) |
| Status | Recruiting |
| Started | January 29, 2026 |
| Main results expected | June 30, 2026 |
| Study ends | December 2026 |
| Registry record updated | May 14, 2026 |
| Trial ID | NCT07387653 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults undergoing prolonged minimally invasive pelvic surgery in lithotomy position, with expected duration over 2 hours.
✕Probably not a fit
Patients whose limb perfusion remains adequate during surgery or who do not develop ischemic changes may not derive a direct benefit from monitoring.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, observational pilot study enrolling about 30 adults undergoing minimally invasive pelvic surgeries in lithotomy position for at least 2 hours. The study uses two non-invasive devices to continuously monitor hemodynamics and tissue oxygenation in the lower limbs to see how often and how long tissue desaturation occurs and how those events relate to later limb pain, sensation, and motor function. It is non-interventional with minimal risk, aiming to generate preliminary data to guide future prevention and detection strategies for limb ischemia and well-leg syndrome. The primary outcome is desaturation frequency and duration; secondary outcomes explore associations with postoperative limb outcomes. Data will inform whether this monitoring approach can enhance early identification of limb ischemia during surgery.
Why it matters
Potential benefit: If successful, this approach could allow earlier detection of limb ischemia during surgery and inform prevention strategies to reduce postoperative limb complications.
How similar studies have gone: Previous non-invasive monitoring methods have shown potential in correlating tissue oxygenation with ischemia in other settings, but this specific paired approach in lithotomy-position surgeries is exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adult patients 2. Undergoing minimally invasive pelvic surgery (such as hysterectomy, myomectomy, or endometriosis surgery) 3. Surgery performed in lithotomy position 4. Expected surgical duration \> 2 hours as determined by the primary surgeon Exclusion Criteria: 1. Pregnant patients 2. Procedures expected to last \< 2 hours 3. Open surgical approaches 4. Minor procedures 5. Known allergy or sensitivity to adhesives used for monitoring sensors 6. Vulnerable populations (incarcerated, elderly or pregnant)
Where it's running
-
Memorial Hermann Hospital
Houston, Texas, United States Recruiting -
Memorial Hermann Medical Center
Houston, Texas, United States Not yet recruiting
Study contacts
- Study coordinator: Randa Jalloul, MD, MS
- Email: randa.j.jalloul@uth.tmc.edu
- Phone: 7134867700
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Home-use Erchonia EVRL laser for temporary relief of idiopathic peripheral neuropathy foot pain
This study will test whether a home-use Erchonia EVRL laser can provide temporary relief of foot pain for adults with idiopathic peripheral neuropathy.
-
Blood microRNA markers for chemotherapy-related peripheral nerve damage in lung and colorectal cancer
This study will test whether levels of tiny blood molecules called microRNAs can predict how often and how badly patients with lung or colorectal cancer get nerve damage from certain chemotherapies.
-
Using neuromodulation to treat pain from chemotherapy-induced peripheral neuropathy
This study is testing a new way to relieve pain from nerve damage caused by chemotherapy in patients with lower extremity CIPN.
-
Electrical stimulation to improve recovery after cubital tunnel surgery
This study is testing a new electrical stimulation treatment to see if it helps people recover better after surgery for cubital tunnel syndrome.
-
Evaluating Ketotifen's protective role against chemotherapy-induced nerve damage
This study is testing if Ketotifen can help prevent nerve damage caused by chemotherapy in people with stage III colorectal cancer.
-
Peripheral nerve block for painful diabetic neuropathy
This study is testing if a nerve block can help adults with painful diabetic neuropathy feel less pain without stopping their regular medications.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.